Two Ligand Pharmaceuticals Board Members Recognized as 2019 Most Influential Corporate Directors by WomenInc. Magazine December 23, 2019
Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol November 8, 2019
Ligand to Participate in the H. C. Wainwright 21st Annual Global Investment Conference August 29, 2019
Ligand Announces Positive Top Line Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol July 10, 2019
Ligand and SQ Innovation Enter into Exclusive Worldwide Captisol® License and Supply Agreements for High-Concentration Furosemide Formulation July 8, 2019